This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Wedbush Sticks to Their Buy Rating for TripAdvisor (TRIP)

Tipranks - Wed Jun 17, 9:00AM CDT

Wedbush analyst Michael Piccolo reiterated a Buy rating on TripAdvisor today and set a price target of $20.00.

Claim 55% Off TipRanks

Piccolo covers the Healthcare sector, focusing on stocks such as Staar Surgical, Cross Country Healthcare, and Solventum Corporation. According to TipRanks, Piccolo has an average return of -7.9% and a 38.89% success rate on recommended stocks.

In addition to Wedbush, TripAdvisor also received a Buy from BTIG’s Jake Fuller in a report issued yesterday. However, on the same day, B. Riley Securities maintained a Hold rating on TripAdvisor (NASDAQ: TRIP).

Based on TripAdvisor’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $382.4 million and a GAAP net loss of $32.4 million. In comparison, last year the company earned a revenue of $398 million and had a GAAP net loss of $11 million

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.